Segments - Nephrology and Urology Devices Market by Product (Stone Basket, Urology Guidewires, Renal Dilators, Ureteral Catheters, PCN Catheters, Urinary Stents, and Others) and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The global nephrology and urology devices market size was USD 5.04 Billion in 2022 and is likely to reach USD 9.03 Billion by 2031, expanding at a CAGR of 6.7% during 2023–2031. The growth of the market is attributed to the expanding senior population, together with the high incidence and prevalence of chronic kidney disease.
Nephrology and urology is a branch of medicine concerned with the study of normal kidney function, kidney disorders, kidney treatment, and renal replacement therapy related to the urinary system. Chronic kidney disease, pelvic organ prolapses and urine incontinence, kidney stone, benign prostatic hyperplasia, and end-stage renal disease are all disorders of the urinary system and kidneys that are treated using nephrology and urology equipment.
The usage of new nephrology and urology devices has expanded dramatically as technology has advanced rapidly. Urologic illnesses are the third-most prevalent issue among the elderly, as stated by the American Society of Nephrology, and the group accounts for almost 47% of physician visits.
The market report finds that the COVID-19 pandemic has fueled the nephrology and urology devices market. The healthcare institutions such as hospitals have been overburdened with an increasing number of patients globally. As a result, several nations have put off elective operations and other medical procedures indefinitely except coronavirus-related treatment services.
However, there has been in surge demand for renal disease treatment devices that can be used in home care settings. Similarly, the demand for home healthcare among the elderly is rising since they are at a higher risk of infection and are unable to visit a healthcare institution.
Diabetes and high blood pressure (hypertension) are two leading causes of kidney failure. Hence, rising global prevalence of these disorders are fueling the market.
Wide prevalence of kidney failure and growing awareness about the availability of advanced treatment devices are key factors that drive the market.
Growing number of the elderly population who are prone to ailments such as renal and urinary problems, is likely to boost the market in the coming years.
Availability of traditional medication and surgical remedies along with the high cost of the use of device treatment are major challenges that can hamper the market growth during the forecast period.
Demand for minimally invasive procedures and the wide integration of recent technological advancements are likely to create lucrative opportunities for the market expansion.
The market report includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Nephrology And Urology Devices Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Product (Stone Basket, Urology Guidewires, Renal Dilators, Ureteral Catheters, PCN Catheters, Urinary Stents, and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
C.R. Bard, Inc.; Cook Group, Inc.; Hollister, Inc.; Nipro Corp.; Terumo Corp.; Coloplast A/S; ConvaTec Group plc; B. Braun AG; Teleflex, Inc.; Asahi Kasei Corp.; Nxstage Medical, Inc.; Medtronic plc; Fresenius Medical Care AG & Co. KGaA; Baxter International, Inc.; and Boston Scientific Corp. |
On the basis of product, the nephrology and urology devices market is segmented into stone basket, urology guidewires, renal dilators, ureteral catheters, percutaneous nephrostomy (PCN) catheters, urinary stents, and others.
The percutaneous nephrostomy catheters segment is anticipated to account for a major market share during the forecast period as PCN catheters has a wide range of uses in urology including the treatment of renal transplant problems, decompression of the perinephric or nephric fluid collection, and nondilated obstructive therapy.
The others segment is projected to expand at a considerable CAGR during the forecast period, due to a high frequency of prostate and colorectal cancer, acute kidney injury, urolithiasis, and the introduction of technologically sophisticated products by major companies.
In terms of region, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to constitute a key share of the market during the projected period, owing to the region's high rate of kidney-related illnesses and supporting government programs for the treatment.
Moreover, the availability of highly qualified physicians and well-established healthcare facilities presents another key driver of the regional market. The market of Asia Pacific is anticipated to expand at a rapid pace during the forecast period, due to a variety of factors including increased knowledge of renal and urinary problems, increased healthcare spending, and improved healthcare facilities in the region.
The global nephrology and urology devices market has been segmented on the basis of
Key players competing in the global nephrology and urology devices market are C.R. Bard, Inc.; Cook Group, Inc.; Hollister, Inc.; Nipro Corp.; Terumo Corp.; Coloplast A/S; ConvaTec Group plc; B. Braun AG; Teleflex, Inc.; Asahi Kasei Corp.; Nxstage Medical, Inc.; Medtronic plc; Fresenius Medical Care AG & Co. KGaA; Baxter International, Inc.; and Boston Scientific Corp.
Companies are actively engaged in launching new goods and expanding their geographic reach in order to achieve a larger market share. For example, a Japanese firm, Terumo Corp. acquired Sequent Medical, a US-based medical device maker through its subsidiary in the United States.
Furthermore, several manufacturers entered into collaborations and partnerships with major medical device distributors to accelerate the sale of their goods worldwide or in certain areas.